4D PHARMA PLC

Company number 08840579

Date	Type	Description	View / Download
08 Jul 2020	RESOLUTIONS	Resolutions RES13 ‐ Market purchases of its ordinary shares to a maximum of 10949384 ordinary shares of not less than 0.25 pence and not more than 5% above the average of the mid market quotations for ordinary shares.receive and adopt the company's annual accounts. To reappoint directors.reappoint auditors. 30/06/2020 RES10 ‐ Resolution of allotment of securities	(2 pages)
03 Jul 2020	SH01	Statement of capital following an allotment of shares on 9 March 2020 GBP 163,734.605	(3 pages)
29 Jun 2020	TM01	Termination of appointment of Thomas Engelen as a director on 21 May 2020	(1 page)
21 Apr 2020	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	(1 page)
07 Feb 2020	CS01	Confirmation statement made on 6 January 2020 with no updates	(3 pages)
06 Feb 2020	TM02	Termination of appointment of Laurence Smith Dale as a secretary on 31 January 2020	(1 page)
06 Feb 2020	AP03	Appointment of Mr Duncan Peyton as a secretary on 31 January 2020	(2 pages)
25 Oct 2019	PSC08	Notification of a person with significant control statement	(2 pages)
25 Oct 2019	PSC07	Cessation of Woodford Investment Management Limited as a person with significant control on 5 July 2019	(1 page)
27 Aug 2019	AP01	Appointment of Dr Alexander Donald Macrae as a director on 26 August 2019	(2 pages)
08 Jul 2019	RESOLUTIONS	Resolutions RES09 ‐ Resolution of authority to purchase a number of shares RES10 ‐ Resolution of allotment of securities	(2 pages)
11 Jun 2019	AA	Group of companies' accounts made up to 31 December 2018	(68 pages)
09 Jan 2019	AP01	Appointment of Professor Dr. Med. Axel Gaston Glasmacher as a director on 7 January 2019	(2 pages)
08 Jan 2019	AP01	Appointment of Dr. Edgardo Baracchini as a director on 7 January 2019	(2 pages)
07 Jan 2019	CS01	Confirmation statement made on 6 January 2019 with no updates	(3 pages)
07 Jan 2019	PSC02	Notification of Woodford Investment Management Limited as a person with significant control on 20 February 2018	(2 pages)
07 Jan 2019	PSC07	Cessation of Woodford Asset Management Llp as a person with significant control on 20 February 2018	(1 page)
04 Jun 2018	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES09 ‐ Resolution of authority to purchase a number of shares RES10 ‐ Resolution of allotment of securities	(2 pages)
14 May 2018	AA	Group of companies' accounts made up to 31 December 2017	(64 pages)
17 Jan 2018	AD02	Register inspection address has been changed from C/O Capita Asset Services 34 Beckenham Road Beckenham Kent BR3 4TU England to Link Asset Services the Registry 34 Beckenham Road Beckenham Kent BR3 4TU	(1 page)
08 Jan 2018	CS01	Confirmation statement made on 6 January 2018 with no updates	(3 pages)
31 Aug 2017	AD01	Registered office address changed from C/O 4D Pharma Plc Third Floor 9 Bond Court Leeds LS1 2JZ England to 4D Pharma Plc 9 Bond Court Leeds LS1 2JZ on 31 August 2017	(1 page)
31 Aug 2017	SH01	Statement of capital following an allotment of shares on 23 August 2017 GBP 163,734.605	(3 pages)
25 Jul 2017	PSC02	Notification of Woodford Asset Management Llp as a person with significant control on 26 June 2017	(1 page)
08 Jun 2017	AA	Group of companies' accounts made up to 31 December 2016	(60 pages)

Previous

• 1
• 2
• 3
• 4
• 5

Next